K-V Pharmaceutical Cl A (KV-A) Balance Sheet

Click line-items for a historical chart and %

ASSETS
Cash and cash equivalents
Investment securities
Restricted cash
Receivables, net
Inventories, net
Other current assets
Current assets held for sale
Total Current Assets
Property and equipment, less accumulated depreciation
Intangible assets, net
Other assets
Non-current assets held for sale
Total Assets
LIABILITIES
Accounts payable
Accrued liabilities
Warrant liability
Current maturities of long-term debt
Current liabilities associated with assets held for sale
Total Current Liabilities
Long-term debt, less current maturities
Other long-term liabilities
Deferred tax liability
Total Liabilities
Commitments and Contingencies
SHAREHOLDERS' DEFICIT
7% cumulative convertible Preferred Stock, $.01 par value; $25.00 stated and liquidation value; 840,000 shares authorized; issued and outstanding -40,000 shares at both June 30, 2011 and March 31, 2011 (convertible into Class A shares on a 8.4375-to-one basis)
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income
Less: Treasury stock, 3,409,050 shares of Class A and 94,572 shares of Class B Common Stock at June 30, 2011 and March 31, 2011, at cost
Total Shareholders' Deficit
Total Liabilities and Shareholders' Deficit
Common Class A [Member]
SHAREHOLDERS' DEFICIT
Common Stock	500K
Common Class B [Member]
SHAREHOLDERS' DEFICIT
Common Stock	100K

Entities mentioned with KV-A

View All Entities